Carlsmed reports 61% revenue growth in Q4 2025
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Carlsmed Inc (CARL)
Carlsmed Inc stock price live, this page displays NASDAQ CARL stock exchange data. View the CARL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Carlsmed Inc real time stock price chart below.
What Is the Carlsmed Inc Stock Price Today?
The Carlsmed Inc stock price today is 11.67.
What Is the Stock Symbol for Carlsmed Inc?
The stock symbol for Carlsmed Inc is "CARL."
What Stock Exchange Does Carlsmed Inc Trade On?
Carlsmed Inc is listed and trades on the NASDAQ stock exchange.
Is Carlsmed Inc a Good Stock to Buy?
Determining whether Carlsmed Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CARL quote. (ISIN: US14280C1053)
What Is the Carlsmed Inc Stock Price Today?
The Carlsmed Inc stock price today is 11.67.
What Is the Stock Symbol for Carlsmed Inc?
The stock symbol for Carlsmed Inc is "CARL."
What Stock Exchange Does Carlsmed Inc Trade On?
Carlsmed Inc is listed and trades on the NASDAQ stock exchange.
Is Carlsmed Inc a Good Stock to Buy?
Determining whether Carlsmed Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CARL quote. (ISIN: US14280C1053)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.10
11.82
52 wk Range
11.10
17.19
Trading near 52-week Low
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.1011.82
52 wk Range
11.1017.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CARL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.40
Upside
+66.24%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Carlsmed Inc Company Profile
Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Carlsmed Inc Earnings Call Summary for Q3/2025
- Carlsmed (CARL) reported 98% YoY revenue growth to $13.1M in Q3 2025, with improved gross margins of 75.9%, despite posting a GAAP net loss of $8.5M and maintaining $115.5M cash position.
- The company launched a digital surgery platform for lumbar spine fusion and reduced production lead times from 20 to 8 days, contributing to 70% growth in surgeon user base.
- Strategic investments expanded Carlsmed's credit facility to $50M while the company achieved an 83% reduction in reoperation rates, positioning it as a leader in spine surgery solutions.
- Management provided full-year revenue guidance of $49-50M (80-84% annual growth) and is preparing for Medicare transitional pass-through payment expected in early 2026.
- CEO Mike Cordonnier emphasized the company's mission to 'establish a new architecture of surgery where patient outcomes are not only more predictable but consistently superior.'
Last Updated: 11/07/2025, 06:36 AM
Read Full TranscriptCompare CARL to Peers and Sector
Metrics to compare | CARL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCARLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.8x | −5.8x | −0.5x | |
PEG Ratio | - | −0.15 | 0.00 | |
Price/Book | 2.9x | 3.8x | 2.6x | |
Price / LTM Sales | 6.9x | 3.2x | 3.3x | |
Upside (Analyst Target) | 54.2% | 50.0% | 45.8% | |
Fair Value Upside | Unlock | 18.4% | 6.4% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.40
(+66.24% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.40 / --
Revenue / Forecast
13.10M / --
People Also Watch
FAQ
What Is the Carlsmed (CARL) Stock Price Today?
The Carlsmed stock price today is 11.67
What Stock Exchange Does Carlsmed Trade On?
Carlsmed is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Carlsmed?
The stock symbol for Carlsmed is "CARL."
What Is the Carlsmed Market Cap?
As of today, Carlsmed market cap is 310.24M.
What Is Carlsmed's Earnings Per Share (TTM)?
The Carlsmed EPS (TTM) is -3.07.
When Is the Next Carlsmed Earnings Date?
Carlsmed will release its next earnings report on Feb 18, 2026.
From a Technical Analysis Perspective, Is CARL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Carlsmed Stock Split?
Carlsmed has split 0 times.
How Many Employees Does Carlsmed Have?
Carlsmed has 89 employees.
What is the current trading status of Carlsmed (CARL)?
As of Feb 07, 2026, Carlsmed (CARL) is trading at a price of 11.67, with a previous close of 11.29. The stock has fluctuated within a day range of 11.10 to 11.82, while its 52-week range spans from 11.10 to 17.19.
What Is Carlsmed (CARL) Price Target According to Analysts?
The average 12-month price target for Carlsmed is USD19.40, with a high estimate of USD24 and a low estimate of USD17. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +66.24% Upside potential.
What Is the CARL Premarket Price?
CARL's last pre-market stock price is 12.03. The pre-market share volume is 101.00, and the stock has decreased by 0.74, or 6.55%.
What Is the CARL After Hours Price?
CARL's last after hours stock price is 11.44, the stock has decreased by -0.23, or -1.97%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.